ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1356	National Cancer Institute	Html	en	Carcinoma of Unknown Primary Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of metastatic cancer that has spread from an unidentified primary tumor.	general cancer information 0.411851 treatment 0.656267 cancer treatment 0.493001 breast cancer cells 0.486603 primary cancer 0.600191 new cancer treatments 0.408458 Peritoneal Cancer Treatment 0.426103 cancer cells 0.712358 tissue 0.443805 malignant tumor cells 0.423112 body 0.560831 type 0.447878 Cancer Information Service 0.414189 Squamous Neck Cancer 0.400297 PDQ cancer information 0.512966 clinical trial search 0.39505 treatment clinical trials 0.437756 certain changes 0.407705 National Cancer Institute 0.54586 clinical trials 0.823063 normal cells 0.410928 cancer information summary 0.471688 clinical trial 0.588388 new treatment 0.44726	breast cancer prevention 0.400005 primary cancer site 0.517081 cancer tissue 0.403216 patients 0.429603 Cancer Care page 0.397493 PDQ summary 0.435669 treatment clinical trial 0.401935 PDQ Adult Treatment 0.398071 NCI PDQ cancer 0.432436 cancer research process 0.400715 cancer clinical trials 0.44656 tests 0.388491 lymph nodes 0.409196 Unknown Primary Treatment 0.395812 carcinoma 0.39749 primary cancer depend 0.439856 lymph node 0.431668 radiation therapy 0.485838 Treatment Editorial Board 0.413559 cancer information summaries 0.411898 comprehensive cancer information 0.411754 cancer 0.945761 standard treatment 0.426236	CLICK HERE
1675	National Cancer Institute	Html	en	Lymphedema (PDQ®)–Health Professional Version	Expert-reviewed information summary about the anatomy, pathophysiology, clinical manifestations, diagnosis, and treatment of cancer-related lymphedema, a condition in which lymph fluid builds up in tissues and causes swelling.	upper-limb lymphedema 0.596897 Manual lymphatic therapy 0.494091 axillary node dissection 0.485114 lymph nodes. 0.472628 upper-extremity lymphedema 0.68666 arm lymphedema 0.638618 lower-limb lymphedema 0.630542 lymph node dissection 0.832229 lower-extremity lymphedema 0.630897 deep lymphatic systems 0.498654 intestinal lymphatic trunk 0.501781 new lymphedema 0.619269 lumbar lymphatic trunk 0.502509 upper extremity lymphedema 0.623186 manual lymphatic drainage 0.477215 lymph collector vessels 0.497637 lymphatic vessels 0.762836 lymphedema onset 0.622585 secondary lymphedema 0.644407 certified lymphedema 0.696216 left subclavian vein 0.475686 lymphedema manifest 0.633761 lymphedema classification 0.594846 protein-rich lymph fluid 0.533977	secondary lymphatic vessels 0.59679 subclavian lymphatic trunk 0.576658 primary lymphatic vessels 0.596665 subcutaneous lymphatic vessels 0.50703 lymphedema 0.987634 breast cancer patients 0.473019 certified lymphedema therapist 0.652056 patients 0.478875 cancer patients 0.474035 Lymph channels 0.46738 lymph node biopsy 0.634545 breast cancer 0.848001 sentinel lymph node 0.728941 certified lymphedema therapists 0.649954 unidirectional lymphatic flow 0.496065 breast cancer survivors 0.505056 axillary lymph node 0.799687 lymph nodes 0.59192 treatable lymphedema 0.590609 lymph node biopsy. 0.539242 manual lymphedema therapy. 0.64813 lymph node drainage 0.539621 manual lymphedema therapy 0.852751	CLICK HERE
1765	National Cancer Institute	Html	en	Physical Activity and Cancer	A fact sheet that summarizes evidence linking exercise and other physical activity, including work and household chores, to reduced cancer risks.	U. Physical activity 0.367372 bone-strengthening physical activity 0.370971 physical activity daily 0.371076 physical activity attenuate 0.362897 better breast cancer 0.3594 low physical activity 0.37763 Breast Cancer Research 0.357155 muscle-strengthening physical activity 0.370998 vigorous physical activity 0.364437 S. Physical activity 0.365821 average breast cancer 0.365315 cancer risk reduction 0.373439 colorectal cancer 0.41572 average endometrial cancer 0.357301 H. Physical activity 0.366033 postdiagnosis physical activity 0.363749 postmenopausal breast cancer 0.379275 lower risk 0.357009 potential physical activity 0.369413 physical activity influence 0.360893 different cancer risk 0.360424 aerobic physical activity 0.386234 vigorous-intensity physical activity 0.373987 cancer survivors 0.406644 Cancer Epidemiology 0.363652	cancer prevention 0.376861 Physical Activity website 0.371276 A. Physical activity 0.364619 breast cancer diagnosis 0.4205 endometrial cancer risk 0.390992 breast cancer recurrence 0.359315 Physical Activity Guidelines 0.371598 links physical activity 0.369787 physical activity benefit 0.375758 National Cancer Institute 0.363045 daily physical activity 0.370902 L. Physical activity 0.366831 breast cancer risk 0.390634 colon cancer 0.375643 meta-analysis 0.376142 breast cancer 0.54813 colon cancer risk 0.372667 systematic review 0.435657 physical activity 0.996162 prostate cancer 0.369869 leisure-time physical activity 0.442557 et al 0.539243 cancer risk 0.441434 recreational physical activity 0.391568	CLICK HERE
1828	National Cancer Institute	Html	es	Tratamiento de la leucemia linfoblástica aguda en adultos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento de la leucemia linfoblástica aguda en adultos.	Italy Leukemia Group 0.510748 prognostic factors 0.523487 in adults 0.649162 tirosina cinasa bcr-abl 0.513926 largo plazo 0.507147 leukemia group 0.574628 or fab l3 0.5087 LLA Ph1 0.523666 chronic myeloid leukemia 0.519002 Thiel E 0.520173 TMO autógeno 0.523146 adults with 0.569541 leucemia mielógena 0.512104 donante fraterno 0.513552 lymphocytic leukemia 0.529118 Löffler H 0.510187 LLA recién 0.516678 induction regimen with 0.509327 in adults with 0.545834 patients with 0.533511 complete remission 0.509903 leucemia mielocítica aguda 0.512148 multicenter study 0.514475 adults with standard-risk 0.510496 myeloid leukemia 0.519806	marrow transplantation 0.523773 leucemia aguda 0.509415 leucemia linfoblástica aguda 0.65786 TMO alogénico 0.56508 bone marrow transplantation 0.52273 morfología l3 0.522238 Hoelzer D 0.525554 leukemia with 0.523655 Adult Leukemia Study 0.507091 Northern Italy Leukemia 0.510296 Horowitz MM 0.508541 LLA L3 0.549875 International ALL Trial 0.508909 PDQ Tratamiento 0.509128 Dodge RK 0.508725 Brief-duration high-intensity chemotherapy 0.50796 bone marrow transplant 0.513671 Clin Oncol 0.534506 sistema nervioso central 0.584696 bone marrow 0.527725 with small noncleaved-cell 0.509543 acute lymphoblastic leukemia 0.981898 leukemia with hyper-CVAD 0.507761 lla recidivante quimioterapia 0.519565	CLICK HERE
2049	National Cancer Institute	Html	es	Trasplantes de células madre formadoras de sangre	Hoja informativa que explica los procedimientos, paso a paso, del trasplante de médula ósea y del trasplante de células madre de sangre periférica, así como sus riesgos y beneficios.	células madre 0.995824 efecto gvt 0.300369 trasplante autólogo 0.304497 PBSCT alogénicos 0.300755 llamadas antígenos 0.300572 frecuencia células madre 0.306001 bone marrow transplantation 0.300883 raros casos 0.300403 Sin embargo 0.307734 catéter venoso central 0.300806 Programa Nacional 0.300971 llamadas células madre 0.30624 largo plazo 0.300324 causa disminución 0.300351 seguro médico 0.300814	cubre be 0.300325 paciente transfusiones 0.301172 HLA compatibles mejora 0.301344 idéntico.  sin embargo 0.300876 antígenos hla 0.303269 stem cell transplantation 0.300928 programa be 0.300461 posibles efectos 0.301054 linfocitos t".  0.3004 atacan.  más 0.300461 GVHD aguda 0.300451 corto plazo 0.30031 sangre.  solo 0.300435 usa dosis 0.301797 tipo hla 0.300841	CLICK HERE
2068	National Cancer Institute	Html	es	Marcadores de tumores	Hoja informativa que explica lo que son los marcadores de tumores y responde preguntas sobre su uso para el diagnóstico y tratamiento del cáncer.	Bast RC Jr 0.727949 cancer screening 0.603977 Gray RJ 0.462067 randomized european study 0.51305 Asociación Estadounidense 0.468124 estudio plco 0.461327 Bigbee W 0.467579 amplia gama 0.464843 afecciones benignas 0.671952 Herberman RB 0.469893 Prevention Research 0.463207 BC Decker Inc 0.509079 Clinical Laboratory Improvement 0.519898 Cancer Screening Randomized 0.544857 Controlled Trial 0.467216 riesgo intermedio 0.462476 Clinical Practice 0.47196 ecografía transvaginal 0.471751 Makower DF 0.466396 estudio tailorx 0.460805 ¿Cuáles marcadores 0.637902 21-gene expression assay 0.514014	Hugosson J 0.463892 Instituto Nacional 0.461324 screening trial specimens 0.541412 Oncología Clínica 0.463202 tumor markers 0.619108 Andriole G 0.463781 Mortality results from 0.526447 Quality Requirements 0.470424 Kufe DW 0.468535 Black A 0.461077 6th ed 0.467056 Oncotype DX® 0.469566 situaciones benignas 0.492829 PubMed Abstract 0.928354 tratamientos resultantes 0.466203 Buys SS 0.460749 Bioquímica Clínica 0.461341 Pollock RE 0.46616 New England Journal 0.930005 Roobol MJ 0.466517 Sparano JA 0.466154 hoja informativa estadificación 0.539118	CLICK HERE
3429	National Cancer Institute	Html	es	Agua fluorada	Hoja informativa que examina los estudios realizados sobre la posible conexión entre el agua fluorada y el cáncer.	Villanacci JF 0.447057 Feltbower RG 0.446597 fluoruro ingerido 0.954566 Mortality Weekly Report 0.483586 vasta cantidad 0.449716 carcinogenicity studies with 0.478781 bajas. Muchos estudios 0.468962 Water Fluoridation Statistics 0.487645 Toxicology Program rodent 0.480514 Napier TS 0.445775 Ewing sarcoma diagnosed 0.483942 Great Britain 0.443018 Disease Control 0.536557 public drinking water 0.505168 National Academy 0.558901 Instituto Nacional 0.520062 agua ayuda 0.629089 Environmental Health 0.58081 Related Programs 0.449277 Estados Unidos 0.666074 Kim FM 0.441491 resultados contradictorios 0.444365 Ingested Fluoride 0.54922 PubMed Abstract 0.93552	among 0-49-year-olds 0.445423 Williams PL 0.44275 salud pública 0.65032 Ad Hoc Subcommittee 0.477798 International Journal 0.533052 Blakey K 0.445319 Dental Research 0.46834 Parslow RC 0.444263 Health Effects 0.572713 Grand Rapids 0.447598 Hejtmancik MR 0.446466 Environmental Health Sciences 0.528481 Hayes C 0.441487 Toft JD 0.447997 drinking water 0.564502 public health 0.755217 National Institute 0.45889 Coordinate Environmental Health 0.506784 prevent dental caries 0.542747 Retrieved August 0.565765 Salud Ambiental 0.441563 National Research Council 0.675505 siglo xx 0.446805 Public Health Service 0.715782	CLICK HERE
3582	National Cancer Institute	Html	en	Frederick National Laboratory for Cancer Research	The FNLCR combines private sector business practices with government infrastructure to conduct research and development in cancer and AIDS.	Frederick National Lab 0.679634 Development Center—one 0.586036 Federally Funded Research 0.723777 FNLCR 0.617129 biomarker identification 0.53533 animal sciences 0.53568 national resource 0.541398 government agencies 0.530109 human clinical trials 0.61809 preclinical assay development 0.712354 oncology-focused computational science 0.628628 cancer research laboratories 0.757218 early development 0.553877 research reagents 0.571396 NCI 0.666268 genetically engineered mouse 0.603734 preclinical research 0.638044 nonprofit research organizations 0.690454 broad charter 0.538883 Leidos Biomedical Research 0.735212 United States 0.647036 Nanotechnology Characterization Laboratory 0.625355 RAS family 0.527528 clinical practice 0.533965	NCI investigators 0.632716 significant cancer research 0.722685 translational genomics 0.544933 cancer research 0.952491 private sector business 0.653242 new drug development 0.647375 government sponsors 0.545164 biomedical research community 0.670235 development needs 0.584975 cancer researchers 0.562687 clinical operations 0.542191 Frederick National Laboratory 0.684108 government infrastructure 0.535486 technical staff 0.530406 preclinical model development 0.704349 private sector resources 0.635668 FNLCR programs 0.564698 National lab staff 0.628876 biomedical computing 0.548325 new cancer therapies 0.637914 frozen tumor samples 0.605424 nanotechnology applications 0.53469 cancer research enterprise 0.705608 basic research 0.59861	CLICK HERE
3604	National Cancer Institute	Html	null	Advancing Precision Medicine in Oncology	Multiyear funding for the Precision Medicine Initiative® (PMI) will help accelerate progress toward the promising new era of precision medicine in oncology.			CLICK HERE
16886	National Cancer Institute	Html	en	Thyroid Cancer Screening (PDQ®)–Health Professional Version	Expert-reviewed information summary about tests used to detect or screen for thyroid cancer.	thyroid cancer trends 0.476323 thyroid tumors 0.422645 United States 0.468063 thyroid cancer screening. 0.46539 cancer registry data 0.363099 thyroid fine-needle aspiration 0.447959 opportunistic thyroid cancer 0.46743 thyroid cancer 0.931034 thyroid cancer incidence 0.631162 Thyroid Cancer Treatment 0.500772 Well-differentiated thyroid cancers 0.495048 palpation screening results 0.370878 total thyroidectomy 0.358528 cancer screening results 0.386186 radioactive iodine 0.350234 South Korea 0.456219 10-year relative survival 0.451331 frequently diagnosed cancer 0.37852 recurrent laryngeal nerve 0.36801 papillary thyroid cancer 0.525506 summary event measure 0.364067 free screening exams 0.364504 follicular thyroid cancers 0.495803 thyroid cancer mortality 0.490522	thyroid cancer overdiagnosis 0.479797 neck palpation 0.364787 cancer incidence rates 0.389027 thyroid cancer deaths. 0.489306 thyroid cancers cases 0.461202 thyroid cancer cases 0.467037 papillary thyroid cancers 0.524728 cancer diagnoses 0.354076 anaplastic thyroid cancers 0.495303 laryngeal nerve injury 0.368292 thyroid cancer screening 0.828908 thyroid cancers 0.597668 thyroid ultrasound 0.428817 suspicious screening result 0.361018 thyroid surgery 0.435882 population-based screening programs 0.366887 national cancer screening 0.412147 medullary thyroid cancer 0.491568 Cancer Screening Guidelines 0.39228 formal screening 0.347128 asymptomatic thyroid cancers 0.481523 incidental thyroid nodules 0.466527 vocal cord 0.353855	CLICK HERE